Precision Bio director awarded 20,979 RSUs

Brown Melinda reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Brown Melinda reported acquisition or exercise transactions in this Form 4 filing.

PRECISION BIOSCIENCES INC director Melinda Brown received a grant of 20,979 restricted stock units (RSUs) tied to common stock. Each RSU represents a right to receive one share of common stock. The RSUs vest on the earlier of June 3, 2027, or the day before the company’s next annual stockholder meeting following the grant date, assuming she continues serving the company through that vesting date. After this grant, she holds 20,979 RSUs directly.

Insider Trade Summary

Grant/Award: 20,979 shares

Grant/Award 1 txn

Insider Brown Melinda

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	20,979	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 20,979 contracts (Direct)

Footnotes (2)

1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
2. F2. The RSUs vest on the earlier to occur of (i) June 3, 2027 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

Key Figures

RSUs granted: 20,979 units RSU holdings after grant: 20,979 units RSU-to-share ratio: 1 RSU = 1 share +1 more

4 metrics

RSUs granted 20,979 units Restricted Stock Units granted to director on June 3, 2026

RSU holdings after grant 20,979 units Total RSUs held directly following the transaction

RSU-to-share ratio 1 RSU = 1 share Each RSU represents a contingent right to one common share

Latest vesting date June 3, 2027 RSUs vest on this date or earlier if before next annual meeting

Key Terms

Restricted Stock Units, RSU, vest, annual meeting of stockholders

4 terms

Restricted Stock Units financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSU financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share"

Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.

vest financial

"The RSUs vest on the earlier to occur of (i) June 3, 2027"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

annual meeting of stockholders financial

"the day immediately prior to the Issuer's next annual meeting of stockholders"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Melinda Brown report in her Form 4 for PRECISION BIOSCIENCES (DTIL)?

Melinda Brown reported receiving 20,979 restricted stock units as a grant. Each RSU represents a contingent right to one share of common stock, providing equity-based compensation that aligns her interests with other shareholders over time.

How many restricted stock units did Melinda Brown acquire in this DTIL filing?

She acquired 20,979 restricted stock units in this transaction. Following the grant, her reported holdings consist of 20,979 RSUs, all held directly, reflecting a compensation-related equity award rather than an open-market stock purchase.

When do Melinda Brown’s newly granted DTIL RSUs vest?

The RSUs vest on the earlier of June 3, 2027, or the day immediately before PRECISION BIOSCIENCES’ next annual stockholder meeting after the grant. Vesting is conditioned on her continued service with the company through the applicable vesting date.

What does each restricted stock unit represent in this PRECISION BIOSCIENCES Form 4?

Each restricted stock unit represents a contingent right to receive one share of PRECISION BIOSCIENCES common stock. The units convert into actual shares only upon vesting, subject to the director continuing to serve the company until that time.

Is Melinda Brown’s DTIL Form 4 transaction a market buy or a compensation grant?

The transaction is a compensation grant, not a market purchase. The Form 4 uses code A, indicating a grant or award acquisition of 20,979 RSUs, which are issued at no cash cost as part of her director compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/05/2026 - 07:39 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brown Melinda

(Last) (First) (Middle)

C/O PRECISION BIOSCIENCES, INC.

302 E. PETTIGREW STREET, SUITE A-100

(Street)

DURHAM NORTH CAROLINA 27701

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PRECISION BIOSCIENCES INC [ DTIL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	06/03/2026		A		20,979		(2)	(2)	Common Stock	20,979	$0	20,979	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

2. The RSUs vest on the earlier to occur of (i) June 3, 2027 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

Remarks:

	/s/ Dario Scimeca, Attorney-in-Fact for Melinda Brown	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)